Your browser doesn't support javascript.
loading
Thymosin α1 therapy in critically ill patients with COVID-19: A multicenter retrospective cohort study.
Wu, Ming; Ji, Jing-Jing; Zhong, Li; Shao, Zi-Yun; Xie, Qi-Feng; Liu, Zhe-Ying; Wang, Cong-Lin; Su, Lei; Feng, Yong-Wen; Liu, Zhi-Feng; Yao, Yong-Ming.
Afiliação
  • Wu M; Department of Critical Care Medicine and Hospital Infection Prevention and Control, The Second People's Hospital of Shenzhen & First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen 518035, China.
  • Ji JJ; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
  • Zhong L; Department of Critical Care Medicine, The First Affiliated Hospital, Guizhou University of Chinese Medicine, Guiyang 550001, China.
  • Shao ZY; Department of Nephrology, General Hospital of Central Theater Command of PLA, Wuhan 430070, China.
  • Xie QF; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
  • Liu ZY; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
  • Wang CL; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
  • Su L; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China.
  • Feng YW; Department of Critical Care Medicine and Hospital Infection Prevention and Control, The Second People's Hospital of Shenzhen & First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen 518035, China. Electronic address: fengyongwen2008@126.com.
  • Liu ZF; Department of Critical Care Medicine, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China; Key Laboratory of Hot Zone Trauma Care and Tissue Repair of PLA, General Hospital of Southern Theater Command of PLA, Guangzhou 510010, China. Electronic address: Zhifengliu7797@163.co
  • Yao YM; Trauma Research Center, Fourth Medical Center and Medical Innovation Research Department of the Chinese PLA General Hospital, Beijing 100048, China. Electronic address: c_ff@sina.com.
Int Immunopharmacol ; 88: 106873, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32795897
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Adjuvantes Imunológicos / Infecções por Coronavirus / Cuidados Críticos / Timalfasina Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pneumonia Viral / Adjuvantes Imunológicos / Infecções por Coronavirus / Cuidados Críticos / Timalfasina Idioma: En Ano de publicação: 2020 Tipo de documento: Article